Associate Professor  Doug Smith

Associate Professor Doug Smith

Associate Professor

School of Biomedical Sciences and Pharmacy (Anatomy)

The age of reason

Dr Doug Smith is investigating the impacts of ageing on the nervous system, with the aim of identifying interventions that will extend healthspan.

Lifespan encapsulates the number of years you are alive, whereas healthspan refers to the number of years you maintain mental and physical health, without serious disease, during your lifespan.

Dr Doug Smith wants you to live better for longer. That doesn't necessarily mean living for longer, although that may be a benefit of good health. He isn't interested in finding the elixir of youth, just the key to maximum healthspan. 

"Some people want to live forever, I have no interest in extending lifespan, I want to extend healthspan, it's a very different thing," he explains.

With life expectancy increasing and family sizes decreasing, our national population is ageing fast, prompting urgency in research in this field.

"In about 20 years from now, there are going to be more people living in Australia who are over the age of 65 then under the age of 15," Doug asserts.

"If more people reach their latter years still in pretty good shape, physically and mentally, then presumably we can lessen the health care cost burden."

"And more importantly, those people will have a better quality of life."

NERVOUS SYSTEMS

With a background in neurobiology, Doug is focusing his study on the impacts of ageing on the nervous system.

The central nervous system (CNS) includes the brain and spinal cord, whilst the peripheral nervous system (PNS) comprises all the body's nerve pathways outside of the CNS. Both the CNS and PNS are affected by ageing.

For example, declining senses, slowing of messages controlling movements, a loss of clarity in cognitive processes and failing memory are all nervous system specific changes that have been attributed to ageing.   

Using an animal model to study the ageing brain, spinal cord and vestibular (balance) system, Doug and his collaborators hope to further understand these changes on a cellular and molecular level.

Together with his team, Doug uses modern genomics approaches, such as next generation sequencing, to obtain a global picture of age-related gene expression changes to inform their directions in the lab.

"There is much more that we don't know than we do know, so doing a discovery driven approach first, that can then can direct us, is very powerful," he says.

Doug and his team then use more traditional hypothesis driven approaches when looking to confirm or refute possible truths suggested by the broader genomics data.

MICRODISSECTION

Utilising laser-capture microdissection (LCMD) technology, the team are able to identify and extract specific cell types from the highly complex nervous system for study.

For example, LCMD extraction allows the team to investigate the effects of ageing on dopamine neurons, the degeneration of which causes Parkinson's disease. They also investigate the breakdown of the blood brain barrier, which is seen in vascular dementia.

Another study saw the team comparing levels of mitochondrial DNA mutation in young and old tissue. Mitochondria are the power generators of a cell and they have their own very small genome. Age-related mutations in this genome are thought to compromise the ability of mitochondria to generate energy for the myriad of cell activities needed for proper nervous system function.

"Based on our genomics findings we are now doing a lipidomics investigation," Doug explains. 

"The CNS is chock full of different types of lipids, and we know they change with ageing, so we are trying to understand those changes in greater detail."

"Once we align these various approaches, it will give us a really good indication of where to head in terms of our more focused or directed studies."

THE NEXT GENERATION SEQUENCERS

Doug credits PhD and undergrad students with undertaking the bulk of the laborious lab work.

"We are always looking for more students who are passionate about biology and who would like to work with us," Doug says and adds, laughing, "Bring your own money!"

A senior lecturer in the School of Biomedical Sciences and Pharmacy, Doug admits that although teaching drains research time and energy, it actually enhances his outcomes.

"I actually believe that teaching is good for your research because when you teach you have to stand back and take a bigger picture view of things," he says.

"And when you do that, sometimes it gives you a different perspective for your research."

Doug was a post-doctoral scientist when a fascination with the biological phenomenon of ageing drew him to this field of study.

"I have always been curious, I have always wanted to know how things work," he conveys.

"Age related degeneration just doesn't make much sense. A lot of energy and effort goes into creating a sexually mature organism. So, why not then just maintain it? I find it very interesting."

AGEING GRACEFULLY

Although studies across species and domains show that ageing has a major impact on both the animal and human body, some individuals seem somewhat resilient to the effects of ageing.

"Everybody has a grandma or elderly uncle that still seems to be running around like a sprightly 30 or 40 year old, both mentally and physically they are doing really well," Doug acknowledges.

"We are trying to determine what it is about these individuals that allows them to have such a good healthspan."

"A potentially disappointing outcome of our work would be that we find out what the cause or causes of ageing are, but we can't find an intervention."

"However, there are many examples of people ageing well, and if you look at what they do, they are all pretty active, not just physically but mentally as well."

FREEDOM OF CHOICE

Due to the mounting evidence, Doug suggests it is more realistic to earn a longer healthspan, than win one in the unexplained resilience to ageing jackpot.

He refers to several existing intervention studies that show vastly different outcomes for participants relative to different diets and levels of exercise.

But don't wait too long. Evidence emerging from Doug's lab suggests the ageing process begins much earlier than we would like to believe.

"Preliminary data is certainly indicating that if you are going to live well, you can't wait until you are 75 and then decide to make healthier choices."

In the end, the solution to retarding the ageing process may simply involve choices around modifying behaviour.

"Once we characterise some of the processes of normal ageing, we can then go and see if a high fat, high sugar, Omega 3, or resveratrol diet, and/or exercise, are going to change the ageing process at the molecular, cellular, organ and whole body levels," Doug explains.

"The next step would be to design interventions that can be applied to human populations. Humans won't like some of the dietary restrictions, or the exercise. The red wine they might go for," he smiles.

"People will always have free will. We are just trying to figure out ways that are acceptable to the majority to help them to age well and stay active for longer."

The age of reason

Dr Doug Smith is investigating the impacts of ageing on the nervous system, with the aim of identifying interventions that will extend healthspan.

Read more

Career Summary

Biography

The main aim of my lab's research is to better understand the effects of ageing on nervous system function. It is well known that the world's population is ageing and soon there will be more people over the age of 65 than there are children. If we are to improve the quality of life of the aged, then we must first understand how ageing affects the body's various physiological systems. As the nervous system has an important role in most functions, its preservation with ageing is paramount.

We are primarily using molecular approaches and focusing on ageing-related changes in the cell's two genomes - the nuclear and mitochondrial genomes. It is well-established that both genomes accumulate mutations with ageing, although it is not completely clear whether these mutations are more detrimental to cell function if they accumulate more so in one of the genomes as opposed to the other. It is also not known whether the mutation accumulations occur in a cell-specific manner. This is particularly important for the nervous system with its highly heterogeneous cell population. A number of nervous system functions appear more susceptible to the ageing process than others. For example, the special senses of hearing, vision and balance are particularly prone, although it remains to be determined whether the peripheral components of these systems (cochlea, retina, and vestibular apparatus, respectively) are more affected than their central nervous system connections and processes.

Cognitive function and motor control are two more nervous system functions that are affected by the ageing process as can be readily observed in the aged population. We are characterising the genomic changes in specific populations of cells within these ageing-affected systems. For example, using state-of-the-art, laser based microdissection, we can collect midbrain dopamine neurons, which play an important role in motor control as can be appreciated from Parkinson's disease, at different ages and determine changes in mitochondrial DNA and the expression level of various genes.

Similar approaches are being used for spinal cord motor neurons and inner ear vestibular hair cells. Knowing how ageing affects the nervous system is important, but we also need to be able to intervene if we are to improve the quality of life of aged individuals. Calorie restriction, whereby the daily calorie intake is reduced by 20-40% (but without malnutrition), is the only presently known intervention that retards the ageing process, at least in animal models. We are establishing CR to determine whether the ageing-related changes we see in the various cell populations of interest are modified by this intervention. If this is the case, we will then set out to determine how CR achieves this.

Research methods used in the lab include: Animal models Laser based microdissection Immunocytochemistry RNA and DNA techniques Real-time and end-point PCR Immunofluorescence microscopy Cryosectioning


Qualifications

  • Doctor of Philosophy, University of Queensland

Keywords

  • Aging and Brain Function
  • Anatomy
  • Animal Models
  • Cell Culture Models
  • Developmental Neurobiology
  • Ergonomics
  • Gene Expression
  • Immunocytochemistry
  • Mitochondrial genomics
  • Modern Techniques
  • Molecular Biology
  • Neuroanatomy
  • Neurobiology
  • Physiology
  • Single Cell Genomics
  • Viral Vectors

Fields of Research

Code Description Percentage
320903 Central nervous system 30
320905 Neurology and neuromuscular diseases 20
320902 Cellular nervous system 50

Professional Experience

UON Appointment

Title Organisation / Department
Associate Professor University of Newcastle
School of Biomedical Sciences and Pharmacy
Australia

Academic appointment

Dates Title Organisation / Department
1/3/2005 - 21/6/2015 Academic University of Newcastle
School of Biomedical Sciences and Pharmacy
Australia
1/7/1997 - 1/4/2004 Research Scientist University of California, San Diego
Department of Pediatrics, School of Medicine UCSD
United States

Awards

Research Award

Year Award
1995 CJ Martin Fellowship
Unknown
Edit

Publications

For publications that are currently unpublished or in-press, details are shown in italics.


Journal article (56 outputs)

Year Citation Altmetrics Link
2023 Poppi LA, Bigland MJ, Cresswell ET, Tabatabaee H, Lorincz D, Drury HR, et al., 'Molecular and Functional Changes to Postsynaptic Cholinergic Signaling in the Vestibular Sensory Organs of Aging C57BL/6 Mice.', J Gerontol A Biol Sci Med Sci, 78 920-929 (2023) [C1]
DOI 10.1093/gerona/glad067
Citations Scopus - 1Web of Science - 1
Co-authors Alan Brichta, Rebecca Lim, Robert Callister
2023 Lorincz D, Drury HR, Smith DW, Lim R, Brichta AM, 'Aged mice are less susceptible to motion sickness and show decreased efferent vestibular activity compared to young adults.', Brain and behavior, 13 e3064 (2023) [C1]
DOI 10.1002/brb3.3064
Co-authors Alan Brichta, Rebecca Lim
2022 Gradwell MA, Smith KM, Dayas CV, Smith DW, Hughes DI, Callister RJ, Graham BA, 'Altered Intrinsic Properties and Inhibitory Connectivity in Aged Parvalbumin-Expressing Dorsal Horn Neurons', FRONTIERS IN NEURAL CIRCUITS, 16 (2022) [C1]
DOI 10.3389/fncir.2022.834173
Citations Scopus - 1
Co-authors Robert Callister, Christopher Dayas, Brett Graham
2020 Madden JF, Davis OC, Boyle KA, Iredale JA, Browne TJ, Callister RJ, et al., 'Functional and Molecular Analysis of Proprioceptive Sensory Neuron Excitability in Mice', Frontiers in Molecular Neuroscience, 13 1-13 (2020) [C1]
DOI 10.3389/fnmol.2020.00036
Citations Scopus - 7Web of Science - 4
Co-authors Phillip Jobling, Jacqueline Iredale, Brett Graham, Robert Callister, Tyler Browne
2020 Mayhew JA, Cummins MJ, Cresswell ET, Callister RJ, Smith DW, Graham BA, 'Age-related gene expression changes in lumbar spinal cord: Implications for neuropathic pain', Molecular Pain, 16 (2020) [C1]

Clinically, pain has an uneven incidence throughout lifespan and impacts more on the elderly. In contrast, preclinical models of pathological pain have typically used juvenile or ... [more]

Clinically, pain has an uneven incidence throughout lifespan and impacts more on the elderly. In contrast, preclinical models of pathological pain have typically used juvenile or young adult animals to highlight the involvement of glial populations, proinflammatory cytokines, and chemokines in the onset and maintenance of pathological signalling in the spinal dorsal horn. The potential impact of this mismatch is also complicated by the growing appreciation that the aged central nervous system exists in a state of chronic inflammation because of enhanced proinflammatory cytokine/chemokine signalling and glial activation. To address this issue, we investigated the impact of aging on the expression of genes that have been associated with neuropathic pain, glial signalling, neurotransmission and neuroinflammation. We used qRT-PCR to quantify gene expression and focussed on the dorsal horn of the spinal cord as this is an important perturbation site in neuropathic pain. To control for global vs region-specific age-related changes in gene expression, the ventral half of the spinal cord was examined. Our results show that expression of proinflammatory chemokines, pattern recognition receptors, and neurotransmitter system components was significantly altered in aged (24¿32 months) versus young mice (2¿4 months). Notably, the magnitude and direction of these changes were spinal-cord region dependent. For example, expression of the chemokine, Cxcl13, increased 119-fold in dorsal spinal cord, but only 2-fold in the ventral spinal cord of old versus young mice. Therefore, we propose the dorsal spinal cord of old animals is subject to region-specific alterations that prime circuits for the development of pathological pain, potentially in the absence of the peripheral triggers normally associated with these conditions.

DOI 10.1177/1744806920971914
Citations Scopus - 5Web of Science - 3
Co-authors Brett Graham, Robert Callister
2019 Duchatel RJ, Harms LR, Meehan CL, Michie PT, Bigland MJ, Smith DW, et al., 'Reduced cortical somatostatin gene expression in a rat model of maternal immune activation', PSYCHIATRY RESEARCH, 282 (2019) [C1]
DOI 10.1016/j.psychres.2019.112621
Citations Scopus - 7Web of Science - 6
Co-authors Ryan Duchatel, Paul Tooney, Lauren Harms, Phillip Jobling, Deborah Hodgson, Pat Michie
2019 Mayhew JA, Callister RJ, Walker FR, Smith DW, Graham BA, 'Aging alters signaling properties in the mouse spinal dorsal horn', MOLECULAR PAIN, 15 (2019) [C1]
DOI 10.1177/1744806919839860
Citations Scopus - 7Web of Science - 6
Co-authors Robert Callister, Brett Graham, Rohan Walker
2018 McIlroy DJ, Minahan K, Keely S, Lott N, Hansbro P, Smith DW, Balogh ZJ, 'Reduced deoxyribonuclease enzyme activity in response to high postinjury mitochondrial DNA concentration provides a therapeutic target for Systemic Inflammatory Response Syndrome', JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 85 354-358 (2018) [C1]
DOI 10.1097/TA.0000000000001919
Citations Scopus - 20Web of Science - 13
Co-authors Zsolt Balogh, Simon Keely
2018 Quinn RK, James MH, Hawkins GE, Brown AL, Heathcote A, Smith DW, et al., 'Temporally specific miRNA expression patterns in the dorsal and ventral striatum of addiction-prone rats', Addiction Biology, 23 631-642 (2018) [C1]

MicroRNAs (miRNAs) within the ventral and dorsal striatum have been shown to regulate addiction-relevant behaviours. However, it is unclear how cocaine experience alone can alter ... [more]

MicroRNAs (miRNAs) within the ventral and dorsal striatum have been shown to regulate addiction-relevant behaviours. However, it is unclear how cocaine experience alone can alter the expression of addiction-relevant miRNAs within striatal subregions. Further, it is not known whether differential expression of miRNAs in the striatum contributes to individual differences in addiction vulnerability. We first examined the effect of cocaine self-administration on the expression of miR-101b, miR-137, miR-212 and miR-132 in nucleus accumbens core and nucleus accumbens shell (NAcSh), as well as dorsomedial striatum and dorsolateral striatum (DLS). We then examined the expression of these same miRNAs in striatal subregions of animals identified as being ¿addiction-prone¿, either immediately following self-administration training or following extinction and relapse testing. Cocaine self-administration was associated with changes in miRNA expression in a regionally discrete manner within the striatum, with the most marked changes occurring in the nucleus accumbens core. When we examined the miRNA profile of addiction-prone rats following self-administration, we observed increased levels of miR-212 in the dorsomedial striatum. After extinction and relapse testing, addiction-prone rats showed significant increases in the expression of miR-101b, miR-137, miR-212 and miR-132 in NAcSh, and miR-137 in the DLS. This study identifies temporally specific changes in miRNA expression consistent with the engagement of distinct striatal subregions across the course of the addiction cycle. Increased dysregulation of miRNA expression in NAcSh and DLS at late stages of the addiction cycle may underlie habitual drug seeking, and may therefore aid in the identification of targets designed to treat addiction.

DOI 10.1111/adb.12520
Citations Scopus - 32Web of Science - 25
Co-authors Guy Hawkins, Murray Cairns, Christopher Dayas, Ajheathcote
2018 Robson AL, Dastoor PC, Flynn J, Palmer W, Martin A, Smith DW, et al., 'Advantages and limitations of current imaging techniques for characterizing liposome morphology', Frontiers in Pharmacology, 9 (2018) [C1]
DOI 10.3389/fphar.2018.00080
Citations Scopus - 110Web of Science - 76
Co-authors Jamie Flynn, Paul Dastoor, Susan Hua
2018 Bigland MJ, Brichta AM, Smith DW, 'Effects of ageing on the mitochondrial genome in rat vestibular organs', Current Aging Science, 11 108-117 (2018) [C1]

Background: Deterioration in vestibular function occurs with ageing and is linked to age-related falls. Sensory hair cells located in the inner ear vestibular labyrinth are critic... [more]

Background: Deterioration in vestibular function occurs with ageing and is linked to age-related falls. Sensory hair cells located in the inner ear vestibular labyrinth are critical to vestibular function. Vestibular hair cells rely predominantly on oxidative phosphorylation (OXPHOS) for energy production and contain numerous mitochondria. Mitochondrial DNA (mtDNA) mutations and perturbed energy production are associated with the ageing process. Objective: We investigated the effects of ageing on mtDNA in vestibular hair and support cells, and vestibular organ gene expression, to better understand mechanisms of age-related vestibular deficits. Methods: Vestibular hair and supporting cell layers were microdissected from young and old rats, and mtDNA was quantified by qPCR. Additionally, vestibular organ gene expression was analysed by microarray and gene set enrichment analyses. Results: In contrast to most other studies, we found no evidence of age-related mtDNA deletion mutations. However, we found an increase in abundance of major arc genes near the mtDNA control region. There was also a marked age-related reduction in mtDNA copy number in both cell types. Vestibular organ gene expression, gene set enrichment analysis showed the OXPHOS pathway was down regulated in old animals. Conclusion: Given the importance of mtDNA to mitochondrial OXPHOS and hair cell function, our findings suggest the vestibular organs are potentially on the brink of an energy crisis in old animals.

DOI 10.2174/1874609811666180830143358
Citations Scopus - 6
Co-authors Alan Brichta
2018 Duchatel RJ, Meehan CL, Harms LR, Michie PT, Bigland MJ, Smith DW, et al., 'Increased complement component 4 (C4) gene expression in the cingulate cortex of rats exposed to late gestation immune activation', SCHIZOPHRENIA RESEARCH, 199 442-444 (2018)
DOI 10.1016/j.schres.2018.03.035
Citations Scopus - 15Web of Science - 12
Co-authors Deborah Hodgson, Lauren Harms, Pat Michie, Phillip Jobling, Ryan Duchatel, Paul Tooney
2018 Duchatel RJ, Meehan CL, Harms LR, Michie PT, Bigland MJ, Smith DW, et al., 'Late gestation immune activation increases IBA1-positive immunoreactivity levels in the corpus callosum of adult rat offspring', Psychiatry Research, 266 175-185 (2018) [C1]

Animal models of maternal immune activation study the effects of infection, an environmental risk factor for schizophrenia, on brain development. Microglia activation and cytokine... [more]

Animal models of maternal immune activation study the effects of infection, an environmental risk factor for schizophrenia, on brain development. Microglia activation and cytokine upregulation may have key roles in schizophrenia neuropathology. We hypothesised that maternal immune activation induces changes in microglia and cytokines in the brains of the adult offspring. Maternal immune activation was induced by injecting polyriboinosinic:polyribocytidylic acid into pregnant rats on gestational day (GD) 10 or GD19, with brain tissue collected from the offspring at adulthood. We observed no change in Iba1, Gfap, IL1-ß and TNF-a mRNA levels in the cingulate cortex (CC) in adult offspring exposed to maternal immune activation. Prenatal exposure to immune activation had a significant main effect on microglial IBA1-positive immunoreactive material (IBA1+IRM) in the corpus callosum; post-hoc analyses identified a significant increase in GD19 offspring, but not GD10. No change in was observed in the CC. In contrast, maternal immune activation had a significant main effect on GFAP+IRM in the CC at GD19 (not GD10); post-hoc analyses only identified a strong trend towards increased GFAP+IRM in the GD19 offspring, with no white matter changes. This suggests late gestation maternal immune activation causes subtle alterations to microglia and astrocytes in the adult offspring.

DOI 10.1016/j.psychres.2018.05.063
Citations Scopus - 11Web of Science - 7
Co-authors Phillip Jobling, Deborah Hodgson, Ryan Duchatel, Rohan Walker, Lauren Harms, Paul Tooney, Pat Michie
2018 Arms L, Smith DW, Flynn J, Palmer W, Martin A, Woldu A, Hua S, 'Advantages and limitations of current techniques for analyzing the biodistribution of nanoparticles', Frontiers in Pharmacology, 9 1-17 (2018) [C1]
DOI 10.3389/fphar.2018.00802
Citations Scopus - 88Web of Science - 47
Co-authors Susan Hua, Jamie Flynn
2017 Khan SI, Hübner PP, Brichta AM, Smith DW, Migliaccio AA, 'Aging reduces the high-frequency and short-term adaptation of the vestibulo-ocular reflex in mice', Neurobiology of Aging, 51 122-131 (2017) [C1]

Prevailing evidence indicates a relatively late life decline in human vestibulo-ocular reflex (VOR) function. Although mice are commonly used in mechanistic studies of vestibular ... [more]

Prevailing evidence indicates a relatively late life decline in human vestibulo-ocular reflex (VOR) function. Although mice are commonly used in mechanistic studies of vestibular function, it remains unclear whether aging produces a corresponding decline in VOR function in mice. We sought to determine how the baseline VOR and its short-term adaptation were affected by aging. We tested 8 young (3-month old) and 8 aged (30-month old¿equivalent to a ~80-year old human) C57BL/6 mice. We measured their VOR response to whole-body static tilts and during 0.1¿10¿Hz whole-body sinusoidal and transient rotations before and after VOR adaptation training. Our data revealed minimal differences in static counter-tilt response between young and aged mice, but a significant deficit in baseline VOR gain in aged mice during transient rotations. Moreover, aged mice had a significant decrease in short-term VOR adaptation, particularly for training that sought to decrease the VOR response.

DOI 10.1016/j.neurobiolaging.2016.12.007
Citations Scopus - 12Web of Science - 10
Co-authors Alan Brichta
2017 Tu L, Poppi L, Rudd J, Cresswell ET, Smith DW, Brichta A, Nalivaiko E, 'Alpha-9 nicotinic acetylcholine receptors mediate hypothermic responses elicited by provocative motion in mice', Physiology and Behavior, 174 114-119 (2017) [C1]

Hypothermic responses accompany motion sickness in humans and can be elicited by provocative motion in rats. We aimed to determine the potential role in these responses of the eff... [more]

Hypothermic responses accompany motion sickness in humans and can be elicited by provocative motion in rats. We aimed to determine the potential role in these responses of the efferent cholinergic vestibular innervation. To this end, we used knockout (KO) mice lacking a9 cholinoreceptor subunit predominantly expressed in the vestibular hair cells and CBA strain as a wild-type (WT) control. In WT mice, circular horizontal motion (1¿Hz, 4¿cm radius, 20¿min) caused rapid and dramatic falls in core body temperature and surface head temperature associated with a transient rise in the tail temperature; these responses were substantially attenuated in KO mice; changes were (WT vs. KO): for the core body temperature¿-¿5.2¿±¿0.3 vs. -¿2.9¿±¿0.3¿°C; for the head skin temperature¿-¿3.3¿±¿0.2 vs. -¿1.7¿±¿0.2¿°C; for the tail skin temperature¿+¿3.9¿±¿1.1 vs¿+¿1.1¿±¿1.2¿°C. There was a close correlation in the time course of cooling the body and the surface of the head. KO mice also required 25% more time to complete a balance test. We conclude: i) that the integrity of cholinergic efferent vestibular system is essential for the full expression of motion-induced hypothermia in mice, and that the role of this system is likely facilitatory; ii) that the system is involvement in control of balance, but the involvement is not major; iii) that in mice, motion-induced body cooling is mediated via increased heat flow through vasodilated tail vasculature and (likely) via reduced thermogenesis. Our results support the idea that hypothermia is a biological correlate of a nausea-like state in animals.

DOI 10.1016/j.physbeh.2017.03.012
Citations Scopus - 21Web of Science - 14
Co-authors Alan Brichta, Eugene Nalivaiko
2016 Parkinson GM, Dayas CV, Smith DW, 'Perturbed cholesterol homeostasis in aging spinal cord', Neurobiology of Aging, 45 123-135 (2016) [C1]

The spinal cord is vital for the processing of sensorimotor information and for its propagation to and from both the brain and the periphery. Spinal cord function is affected by a... [more]

The spinal cord is vital for the processing of sensorimotor information and for its propagation to and from both the brain and the periphery. Spinal cord function is affected by aging, however, the mechanisms involved are not well-understood. To characterize molecular mechanisms of spinal cord aging, microarray analyses of gene expression were performed on cervical spinal cords of aging rats. Of the metabolic and signaling pathways affected, cholesterol-associated pathways were the most comprehensively altered, including significant downregulation of cholesterol synthesis-related genes and upregulation of cholesterol transport and metabolism genes. Paradoxically, a significant increase in total cholesterol content was observed-likely associated with cholesterol ester accumulation. To investigate potential mechanisms for the perturbed cholesterol homeostasis, we quantified the expression of myelin and neuroinflammation-associated genes and proteins. Although there was minimal change in myelin-related expression, there was an increase in phagocytic microglial and astrogliosis markers, particularly in the white matter. Together, these results suggest that perturbed cholesterol homeostasis, possibly as a result of increased inflammatory activation in spinal cord white matter, may contribute to impaired spinal cord function with aging.

DOI 10.1016/j.neurobiolaging.2016.05.017
Citations Scopus - 9Web of Science - 9
Co-authors Christopher Dayas
2016 James MH, Quinn RK, Ong LK, Levi EM, Smith DW, Dickson PW, Dayas CV, 'Rapamycin reduces motivated responding for cocaine and alters GluA1 expression in the ventral but not dorsal striatum', European Journal of Pharmacology, 784 147-154 (2016) [C1]

The mechanistic target of rapamycin complex 1 (mTORC1) regulates synaptic protein synthesis and therefore synaptic function and plasticity. A role for mTORC1 has recently been dem... [more]

The mechanistic target of rapamycin complex 1 (mTORC1) regulates synaptic protein synthesis and therefore synaptic function and plasticity. A role for mTORC1 has recently been demonstrated for addiction-related behaviors. For example, central or intra-accumbal injections of the mTORC1 inhibitor rapamycin attenuates several indices of cocaine-seeking including progressive ratio (PR) responding and reinstatement. These behavioral effects are associated with decreased mTORC1 activity and synaptic protein translation in the nucleus accumbens (NAC) and point to a possible therapeutic role for rapamycin in the treatment of addiction. Currently, it is unclear whether similar behavioral and biochemical effects can be achieved by administering rapamycin systemically, which represents a more clinically-appropriate route of administration. Here, we assessed the effects of repeated, systemic administration of rapamycin (10 mg/kg, i.p.) on PR responding for cocaine. We also assessed whether systemic rapamycin was associated with changes in measures of mTORC1 activity and GluA1 expression in the ventral and dorsal striatum. We report that systemic rapamycin treatment reduced PR breakpoints to levels comparable to intra-NAC rapamycin. Systemic rapamycin treatment also reduced phosphorylated p70S6K and GluA1 AMPARs within the NAC but not dorsal striatum. Thus, systemic administration of rapamycin is as effective at reducing drug seeking behavior and measures of mTORC1 activity compared to direct accumbal application and may therefore represent a possible therapeutic option in the treatment of addiction. Possible caveats of this treatment approach are discussed.

DOI 10.1016/j.ejphar.2016.05.013
Citations Scopus - 23Web of Science - 22
Co-authors Christopher Dayas, Phil Dickson
2016 Murray HC, Maltby VE, Smith DW, Bowden NA, 'Nucleotide excision repair deficiency in melanoma in response to UVA', Experimental Hematology and Oncology, 5 (2016) [C1]

Background: The causative link between UV exposure and melanoma development is well known, however the mechanistic relationship remains incompletely characterised. UVA and UVB com... [more]

Background: The causative link between UV exposure and melanoma development is well known, however the mechanistic relationship remains incompletely characterised. UVA and UVB components of sunlight are implicated in melanomagenesis; however the majority of studies have focused on the effects of UVB and UVC light. Interestingly, melanoma tumour sequencing has revealed an overrepresentation of mutations signature of unrepaired UV-induced DNA damage. Repair of UVA-induced DNA damage is thought to occur primarily through the Nucleotide Excision Repair (NER) pathway, which recognises and repairs damage either coupled to transcription (Transcription Coupled Repair; TCR), or through global genome scanning (Global Genome Repair; GGR). Current literature suggests NER is deficient in melanoma, however the cause of this remains unknown; and whether reduced NER activity in response to UVA may be involved in melanoma development remains uncharacterised. In this study we aimed to determine if melanoma cells exhibit reduced levels of NER activity in response to UVA. Methods: Melanocyte and melanoma cell lines were UVA-irradiated, and DNA damage levels assessed by immunodetection of Cyclobutane Pyrimidine Dimer (CPD) and (6-4) Photoproduct [(6-4)PP] lesions. Expression of NER pathway components and p53 following UVA treatment was quantified by qPCR and western blot. Results: UVA did not induce detectable induction of (6-4)PP lesions, consistent with previous studies. Repair of CPDs induced by UVA was initiated at 4 h and complete within 48 h in normal melanocytes, whereas repair initiation was delayed to 24 h and >40 % of lesions remained in melanoma cell lines at 48 h. This was coupled with a delayed and reduced induction of GGR component XPC in melanoma cells, independent of p53. Conclusion: These findings support that NER activity is reduced in melanoma cells due to deficient GGR. Further investigation into the role of NER in UVA-induced melanomagenesis is warranted and may have implications for melanoma treatment.

DOI 10.1186/s40164-016-0035-4
Citations Scopus - 23Web of Science - 15
Co-authors Vicki E Maltby, Heather Murray, Nikola Bowden
2015 McIlroy DJ, Bigland M, White AE, Hardy BM, Lott N, Smith DW, Balogh ZJ, 'Cell necrosis-independent sustained mitochondrial and nuclear DNA release following trauma surgery', JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 78 282-288 (2015) [C1]
DOI 10.1097/TA.0000000000000519
Citations Scopus - 51Web of Science - 43
Co-authors Zsolt Balogh
2015 Quinn RK, Brown AL, Goldie BJ, Levi EM, Dickson PW, Smith DW, et al., 'Distinct miRNA expression in dorsal striatal subregions is associated with risk for addiction in rats', Translational Psychiatry, 5 (2015) [C1]

Recently, we published data using an animal model that allowed us to characterize animals into two groups, addiction vulnerable and addiction resilient, where we identified that a... [more]

Recently, we published data using an animal model that allowed us to characterize animals into two groups, addiction vulnerable and addiction resilient, where we identified that addiction/relapse vulnerability was associated with deficits in synaptic plasticityassociated gene expression in the dorsal striatum (DS). Notable was the strong reduction in expression for activity-regulated cytoskeleton-associated protein (Arc) considered a master regulator of synaptic plasticity. In the present study, we confirmed that Arc messenger RNA was significantly decreased in the DS, but importantly, we identified that this reduction was restricted to the dorsomedial (DMS) and not dorsolateral striatum (DLS). There is recent evidence of microRNA (miRNA)-associated posttranscriptional suppression of Arc and animal models of addiction have identified a key role for miRNA in the regulation of addiction-relevant genes. In further support of this link, we identified several differentially expressed miRNA with the potential to influence addiction-relevant plasticity genes, including Arc. A key study recently reported that miR-212 expression is protective against compulsive cocaine-seeking. Supporting this hypothesis, we found that miR-212 expression was significantly reduced in the DMS but not DLS of addiction-vulnerable animals. Together, our data provide strong evidence that miRNA promote ongoing plasticity deficits in the DS of addiction-vulnerable animals.

DOI 10.1038/tp.2014.144
Citations Scopus - 28Web of Science - 24
Co-authors Phil Dickson, Murray Cairns, Christopher Dayas
2015 Parkinson GM, Dayas CV, Smith DW, 'Age-related gene expression changes in substantia nigra dopamine neurons of the rat.', Mech Ageing Dev, 149 41-49 (2015) [C1]
DOI 10.1016/j.mad.2015.06.002
Citations Scopus - 16Web of Science - 12
Co-authors Christopher Dayas
2015 Thomas J, Garg ML, Smith DW, 'Effects of dietary supplementation with docosahexaenoic acid (DHA) on hippocampal gene expression in streptozotocin induced diabetic C57Bl/6 mice', Journal of Nutrition and Intermediary Metabolism, 2 2-7 (2015) [C1]

A body of evidence has accumulated indicating diabetes is associated with cognitive impairments. Effective strategies are therefore needed that will delay or prevent the onset of ... [more]

A body of evidence has accumulated indicating diabetes is associated with cognitive impairments. Effective strategies are therefore needed that will delay or prevent the onset of these diabetes-related deficits. In this regard, dietary modification with the naturally occurring compound, docosahexaenoic acid (DHA), holds significant promise as it has been shown to have anti-inflammatory, anti-oxidant, and anti-apoptotic properties. The hippocampus, a limbic structure involved in cognitive functions such as memory formation, is particularly vulnerable to the neurotoxic effects related to diabetes, and we have previously shown that streptozotocin-induced diabetes alters hippocampal gene expression, including genes involved in synaptic plasticity and neurogenesis. In the present study, we explored the effects of dietary supplementation with DHA on hippocampal gene expression in C57Bl/6 diabetic mice. Diabetes was established using streptozotocin (STZ) and once stable, the dietary intervention group received AIN93G diet supplemented with DHA (50 mg/kg/day) for 6 weeks. Microarray based genome-wide expression analysis was carried out on the hippocampus of DHA supplemented diabetic mice and confirmed by real time polymerase chain reaction (RT-qPCR). Genome-wide analysis identified 353 differentially expressed genes compared to non-supplemented diabetic mice. For example, six weeks of dietary DHA supplementation resulted in increased hippocampal expression of Igf II and Sirt1 and decreased expression of Tnf-a, Il6, Mapkapk2 and ApoE, compared to non-supplemented diabetic mice. Overall, DHA supplementation appears to alter hippocampal gene expression in a way that is consistent with it being neuroprotective in the context of the metabolic and inflammatory insults associated with diabetes.

DOI 10.1016/j.jnim.2015.04.001
Citations Scopus - 1
Co-authors Manohar Garg
2014 James MH, Quinn RK, Ong LK, Levi EM, Charnley JL, Smith DW, et al., 'mTORC1 inhibition in the nucleus accumbens 'protects' against the expression of drug seeking and 'relapse' and is associated with reductions in GluA1 AMPAR and CAMKIIa levels.', Neuropsychopharmacology, 39 1694-1702 (2014) [C1]
DOI 10.1038/npp.2014.16
Citations Scopus - 29Web of Science - 24
Co-authors Phil Dickson, Christopher Dayas
2014 McIlroy DJ, Jarnicki AG, Au GG, Lott N, Smith DW, Hansbro PM, Balogh ZJ, 'Mitochondrial DNA neutrophil extracellular traps are formed after trauma and subsequent surgery', Journal of Critical Care, 29 1133.e1-1133.e5 (2014) [C1]

Introduction: Neutrophil extracellular traps (NETs) have not been demonstrated after trauma and subsequent surgery. Neutrophil extracellular traps are formed from pure mitochondri... [more]

Introduction: Neutrophil extracellular traps (NETs) have not been demonstrated after trauma and subsequent surgery. Neutrophil extracellular traps are formed from pure mitochondrial DNA (mtDNA) under certain conditions, which is potently proinflammatory. We hypothesized that injury and orthopedic trauma surgery would induce NET production with mtDNA as a structural component. Methods: Neutrophils were isolated 8 trauma patients requiring orthopedic surgery postinjury and up to 5 days postoperatively. Four healthy volunteers provided positive and negative controls. Total hip replacement patients acted as an uninjured surgical control group. Neutrophil extracellular traps were visualized with DNA (Hoechst 33342TM/Sytox Green/MitoSox/MitoTracker) stains using live cell fluorescence microscopy with downstream quantitative polymerase chain reaction analysis of DNA composition. Results: Neutrophil extracellular traps were present after injury in all 8 trauma patients. They persisted for 5 days postoperatively. Delayed surgery resulted in NET resolution, but they reformed postoperatively. Total hip replacement patients developed NETs postoperatively, which resolved by day 5. Quantitative polymerase chain reaction analysis of NET-DNA composition revealed that NETs formed after injury and surgery were made of mtDNA with no detectable nuclear DNA component. Conclusions: Neutrophil extracellular traps formed after major trauma and subsequent surgery contain mtDNA and represent a novel marker of heightened innate immune activation. They could be considered when timing surgery after trauma to prevent systemic NET-induced inflammatory complications.

DOI 10.1016/j.jcrc.2014.07.013
Citations Scopus - 130Web of Science - 100
Co-authors Zsolt Balogh, Gough Au
2014 Thomas J, Garg ML, Smith DW, 'Dietary resveratrol supplementation normalizes gene expression in the hippocampus of streptozotocin-induced diabetic C57Bl/6 mice', Journal of Nutritional Biochemistry, 25 313-318 (2014) [C1]

Diabetes is associated with cognitive impairment and brain aging, with alterations in hippocampal neurogenesis and synaptic plasticity implicated in these changes. As the prevalen... [more]

Diabetes is associated with cognitive impairment and brain aging, with alterations in hippocampal neurogenesis and synaptic plasticity implicated in these changes. As the prevalence of diabetes continues to rise, readily implemented strategies are increasingly needed in order to protect the brain's cognitive functions. One possibility is resveratrol (RES) (3,5,4- trihydroxystilbene), a polyphenol of the phytoalexin family that has been shown to be protective in a number of neuropathology paradigms. In the present study, we sought to determine whether dietary supplementation with RES has potential for the protection of cognitive functions in diabetes. Diabetes was induced using streptozotocin, and once stable, animals received AIN93G rodent diet supplemented with RES for 6 weeks. Genome-wide expression analysis was conducted on the hippocampus and genes of interest were confirmed by quantitative, real-time polymerase chain reaction. Genome-wide gene expression analysis of the hippocampus revealed that RES supplementation of the diabetic group resulted in 481differentially expressed genes compared to non-supplemented diabetic mice. Intriguingly, gene expression that was previously found significantly altered in the hippocampus of diabetic mice, and that is implicated in neurogenesis and synaptic plasticity (Hdac4, Hat1, Wnt7a, ApoE), was normalized following RES supplementation. In addition, pathway analysis revealed Jak-Stat signaling was the most significantly enriched pathway. The Jak-Stat pathway induces a pro-inflammatory signaling cascade, and we found most genes involved in this cascade (e.g. Il15, Il22, Socs2, Socs5) had significantly lower expression following RES supplementation. These data indicate RES could be neuroprotective and beneficial for the maintenance of cognitive function in diabetes. © 2014 Elsevier Inc.

DOI 10.1016/j.jnutbio.2013.11.005
Citations Scopus - 30Web of Science - 26
Co-authors Manohar Garg
2014 Parkinson GM, Dayas CV, Smith DW, 'Increased mitochondrial DNA deletions in substantia nigra dopamine neurons of the aged rat.', Current aging science, 7 155-160 (2014) [C2]
DOI 10.2174/1874609808666150122150850
Citations Scopus - 18
Co-authors Christopher Dayas
2014 James MH, Campbell EJ, Walker FR, Smith DW, Richardson HN, Hodgson DM, Dayas CV, 'Exercise reverses the effects of early life stress on orexin cell reactivity in male but not female rats', Frontiers in Behavioral Neuroscience, 8 (2014) [C1]
DOI 10.3389/fnbeh.2014.00244
Citations Scopus - 59Web of Science - 49
Co-authors Christopher Dayas, Deborah Hodgson, Erin J Campbell, Rohan Walker
2013 Balogh ZJ, McIlroy DJ, Smith DW, Hansbro PM, 'The origin and the role of mitochondrial DNA in postinjury inflammation', Journal of Critical Care, 28 1099-1100 (2013) [C3]
DOI 10.1016/j.jcrc.2013.08.027
Citations Scopus - 10Web of Science - 9
Co-authors Zsolt Balogh
2013 Thomas J, Garg ML, Smith DW, 'Altered expression of histone and synaptic plasticity associated genes in the hippocampus of streptozotocin-induced diabetic mice', Metabolic Brain Disease, 28 613-618 (2013) [C1]
DOI 10.1007/s11011-013-9418-y
Citations Scopus - 22Web of Science - 16
Co-authors Manohar Garg
2013 Thomas J, Garg ML, Smith DW, 'Dietary supplementation with resveratrol and/or docosahexaenoic acid alters hippocampal gene expression in adult C57Bl/6 mice', Journal of Nutritional Biochemistry, 24 1735-1740 (2013) [C1]

The hippocampus is an important brain structure for multiple cognitive functions, including memory formation. It is particularly sensitive to insults, such as stress, ischemia, an... [more]

The hippocampus is an important brain structure for multiple cognitive functions, including memory formation. It is particularly sensitive to insults, such as stress, ischemia, and aging; all of these can affect hippocampal and therefore cognitive function. To understand the potential of diet for the preservation of hippocampal function, we investigated the effects of dietary supplementation with resveratrol (RES) or docosahexaenoic acid (DHA), or their combination, on hippocampal gene expression in adult C57BL/6 mice. Animals in the supplemented group received either 50 mg/kg/day of RES or DHA, while the combination group received 50 mg/kg/day of each supplement. Dietary supplements were mixed with the AIN93G diet, and supplementation lasted 6 weeks. The control group received AIN93G diet alone for the same period. At the end of the experiment, the hippocampi were processed for genome-wide gene expression and pathway analyses. Most of the genes that were significantly altered were associated with inflammatory responses as determined by pathway analysis. RES-supplemented animals showed decreased expression of IL-6 ( P=001), MAPKapk2 ( P=015), and increased expression for PI3. KR2 ( P=034) and Wnt7a ( P=004) expression. DHA-supplemented animals showed a decreased IL-6 ( P=003) and an increased Wnt7a ( P=003) expression. Animals on the combination diet showed a decreased IL-6 ( P=005) and Apolipoprotien E ( ApoE) ( P=035) expression. Our findings demonstrate that hippocampal gene expression is significantly altered by all three dietary supplementation regimes. Moreover, our analysis indicates that RES and DHA likely exert their beneficial effects through antiinflammatory mechanisms. © 2013 Elsevier Inc.

DOI 10.1016/j.jnutbio.2013.03.002
Citations Scopus - 18Web of Science - 17
Co-authors Manohar Garg
2013 Cahif A, Parkinson GM, Dayas CV, Smith DW, 'Characterisation of mitochondrial DNA deletions by long-PCR in central nervous system regions of young, middle- and old-aged rats.', Current Aging Science, 6 232-238 (2013) [C1]
Citations Scopus - 4
Co-authors Christopher Dayas
2013 Brown AL, Day TA, Dayas CV, Smith DW, 'Purity and Enrichment of Laser-Microdissected Midbrain Dopamine Neurons', BIOMED RESEARCH INTERNATIONAL, 2013 (2013) [C1]
DOI 10.1155/2013/747938
Citations Scopus - 11Web of Science - 9
Co-authors Christopher Dayas, Trevor Day
2012 Barreto RDA, Walker FR, Dunkley PR, Day TA, Smith DW, 'Fluoxetine prevents development of an early stress-related molecular signature in the rat infralimbic medial prefrontal cortex. Implications for depression?', BMC Neuroscience, 13 1-12 (2012) [C1]
Citations Scopus - 30Web of Science - 29
Co-authors Peter Dunkley, Rohan Walker, Trevor Day
2012 Dayas CV, Smith DW, Dunkley PR, 'An emerging role for the mammalian Target of Rapamycin (mTOR) in 'pathological' protein translation: Relevance to cocaine addiction', Frontiers in Pharmacology, 3 1-12 (2012) [C1]
Citations Scopus - 31Web of Science - 29
Co-authors Christopher Dayas, Peter Dunkley
2011 James MH, Charnley JL, Flynn JR, Smith DW, Dayas CV, 'Propensity to 'relapse' following exposure to cocaine cues is associated with the recruitment of specific thalamic and epithalamic nuclei', Neuroscience, 199 235-242 (2011) [C1]
Citations Scopus - 68Web of Science - 61
Co-authors Christopher Dayas, Jamie Flynn
2011 James MH, Charnley JL, Levi EM, Jones E, Yeoh JW, Smith DW, Dayas CV, 'Orexin-1 receptor signalling within the ventral tegmental area, but not the paraventricular thalamus, is critical to regulating cue-induced reinstatement of cocaine-seeking', International Journal of Neuropsychopharmacology, 14 684-690 (2011) [C1]
DOI 10.1017/s1461145711000423
Citations Scopus - 119Web of Science - 108
Co-authors Christopher Dayas
2011 Brown AL, Flynn JR, Smith DW, Dayas CV, 'Down-regulated striatal gene expression for synaptic plasticity-associated proteins in addiction and relapse vulnerable animals', International Journal of Neuropsychopharmacology, 14 1099-1110 (2011) [C1]
Citations Scopus - 30Web of Science - 29
Co-authors Jamie Flynn, Christopher Dayas
2010 James MH, Charnley JL, Jones E, Levi E, Yeoh JW, Flynn JR, et al., 'Cocaine- and amphetamine-regulated transcript (CART) signaling within the paraventricular thalamus modulates cocaine-seeking behaviour', Plos One, 5 e12980 (2010) [C1]
DOI 10.1371/journal.pone.0012980
Citations Scopus - 95Web of Science - 88
Co-authors Jamie Flynn, Christopher Dayas
2009 McInerny SC, Brown AL, Smith DW, 'Region-specific changes in mitochondrial D-loop in aged rat CNS', Mechanisms of Ageing and Development, 130 343-349 (2009) [C1]
DOI 10.1016/j.mad.2009.01.008
Citations Scopus - 30Web of Science - 23
2009 Brown AL, Smith DW, 'Improved RNA preservation for immunolabeling and laser microdissection', RNA: A Publication of the RNA Society, 15 2364-2374 (2009) [C1]
DOI 10.1261/rna.1733509
Citations Scopus - 26Web of Science - 24
2007 Smith DW, Jinnah HA, 'Role of neuronal nitric oxide in the dopamine deficit of HPRT-deficient mice', Metabolic Brain Disease, 22 39-43 (2007) [C1]
DOI 10.1007/s11011-007-9044-7
Citations Scopus - 4Web of Science - 3
2004 Smith DW, Friedmann T, 'Discrepant effects of culture conditions on survival and function of dopaminergic neurons.', Neuroreport, 15 1025-1028 (2004) [C1]
DOI 10.1097/00001756-200404290-00018
Citations Scopus - 5Web of Science - 5
2003 Tokumine J, Kakinohana O, Cizkova D, Smith DW, Marsala M, 'Changes in spinal GDNF, BDNF and NT-3 expression after transient spinal cord ischemia in the rat.', Neuroscience Research, 74 552-561 (2003) [C1]
DOI 10.1002/jnr.10760
Citations Scopus - 71Web of Science - 68
2003 Smith DW, Day TA, 'Catecholamine and oxytocin cells respond to hypovolaemia as well as hypotension', Neuroreport, 14 1493-1495 (2003) [C1]
DOI 10.1097/00001756-200308060-00018
Citations Scopus - 13Web of Science - 13
Co-authors Trevor Day
2002 Visser JE, Smith DW, Fried T, Rothstein JD, Jinnah HA, 'Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease.', Brain Res Dev Brain Res, (2002) [C1]
Citations Scopus - 42Web of Science - 36
2000 Smith DW, Friedmann T, 'Characterization of the dopamine defect in primary cultures of dopaminergic neurons from hypoxanthine phosphoribosyltransferase knockout mice', MOLECULAR THERAPY, 1 486-491 (2000)
DOI 10.1006/mthe.2000.0057
Citations Scopus - 24Web of Science - 19
1999 Buller KM, Smith DW, Day TA, 'Differential recruitment of hypothalamic neuroendocrine and ventrolateral medulla catecholamine cells by non-hypotensive and hypotensive hemorrhages', BRAIN RESEARCH, 834 42-54 (1999)
DOI 10.1016/S0006-8993(99)01539-5
Citations Scopus - 64Web of Science - 63
1999 Buller KM, Smith DW, Day TA, 'NTS catecholamine cell recruitment by hemorrhage and hypoxia', NEUROREPORT, 10 3853-3856 (1999)
DOI 10.1097/00001756-199912160-00024
Citations Scopus - 33Web of Science - 33
1995 SMITH DW, SIBBALD JR, KHANNA S, DAY TA, 'RAT VASOPRESSIN CELL RESPONSES TO SIMULATED HEMORRHAGE - STIMULUS-DEPENDENT ROLE FOR A1 NORADRENERGIC NEURONS', AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 268 R1336-R1342 (1995)
DOI 10.1152/ajpregu.1995.268.5.R1336
Citations Scopus - 46Web of Science - 44
1995 SMITH DW, DAY TA, 'HYPOVOLEMIC AND OSMOTIC STIMULI INDUCE DISTINCT PATTERNS OF C-FOS EXPRESSION IN THE RAT SUBFORNICAL ORGAN', BRAIN RESEARCH, 698 232-236 (1995)
DOI 10.1016/0006-8993(95)00975-V
Citations Scopus - 28Web of Science - 26
1995 Smith DW, Buller KM, Day TA, 'Role of ventrolateral medulla catecholamine cells in hypothalamic neuroendocrine cell responses to systemic hypoxia', JOURNAL OF NEUROSCIENCE, 15 7979-7988 (1995)
Citations Scopus - 96Web of Science - 86
1994 SMITH DW, DAY TA, 'C-FOS EXPRESSION IN HYPOTHALAMIC NEUROSECRETORY AND BRAIN-STEM CATECHOLAMINE CELLS FOLLOWING NOXIOUS SOMATIC STIMULI', NEUROSCIENCE, 58 765-775 (1994)
DOI 10.1016/0306-4522(94)90453-7
Citations Scopus - 53Web of Science - 49
1994 KHANNA S, SIBBALD JR, SMITH DW, DAY TA, 'INITIATION OF RAT VASOPRESSIN CELL RESPONSES TO SIMULATED HYPOTENSIVE HEMORRHAGE', AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 267 R1142-R1149 (1994)
DOI 10.1152/ajpregu.1994.267.4.R1142
Citations Scopus - 21Web of Science - 23
1993 SMITH DW, DAY TA, 'NEUROCHEMICAL IDENTIFICATION OF FOS-POSITIVE NEURONS USING 2-COLOR IMMUNOPEROXIDASE STAINING', JOURNAL OF NEUROSCIENCE METHODS, 47 73-83 (1993)
DOI 10.1016/0165-0270(93)90023-K
Citations Scopus - 42Web of Science - 42
1992 DAY TA, SIBBALD JR, SMITH DW, 'A1-NEURONS AND EXCITATORY AMINO-ACID RECEPTORS IN RAT CAUDAL MEDULLA MEDIATE VAGAL EXCITATION OF SUPRAOPTIC VASOPRESSIN CELLS', BRAIN RESEARCH, 594 244-252 (1992)
DOI 10.1016/0006-8993(92)91131-W
Citations Scopus - 42Web of Science - 45
Show 53 more journal articles

Conference (15 outputs)

Year Citation Altmetrics Link
2015 Dickinson S, Smith K, Bigland M, Smith D, Jobling P, Graham B, 'Morphological analysis of microglial and astrocyte populations in the superficial dorsal horn of spinal cord in aged mice', JOURNAL OF NEUROCHEMISTRY, Cairns, AUSTRALIA (2015) [E3]
Co-authors Brett Graham, Phillip Jobling
2014 Khan SI, Hübner PP, Smith DW, Brichta AM, Migliaccio AA, 'Ageing reduces vestibulo-ocular reflex adaptation in mice J Vestib Res', Journal of Vestibular Research: Equilibrium and Orientation: an international journal of experimental and clinical vestibular science (2014) [E3]
DOI 10.3233/VES-140517
Co-authors Alan Brichta
2013 Bigland M, Parkinson G, Brichta AM, Smith DW, 'Evidence for mitochondrial DNA deletions in vestibular hair cells of the aged rat', Proceedings of the Australian Neuroscience Society, Melbourne (2013) [E3]
Co-authors Alan Brichta
2012 Parkinson GM, Smith DW, 'Age-related increase in mitochondrial DNA copy number in midbrain dopamine neurons of the rat', Abstracts. Australian Neuroscience Society 32nd Annual Meeting, Gold Coast, Queensland (2012) [E3]
2012 James MH, Charnley JL, Levi EM, Dunkley PR, Smith DW, Dickson PW, Dayas CV, 'A role for the mTOR pathway in the development of addiction', Abstracts. Australian Neuroscience Society 32nd Annual Meeting, Gold Coast, Queensland (2012) [E3]
Co-authors Phil Dickson, Christopher Dayas, Peter Dunkley
2012 Thomas J, Smith DW, Garg ML, 'Early molecular signature of neuro-protection in hippocampus of resveratrol diet fed C57BL/6 mice', Resveratrol 2012. 2nd International Conference of Resveratrol and Health, Leicester, UK (2012) [E3]
Co-authors Manohar Garg
2012 Brown AL, Flynn JR, Dayas CV, Smith DW, 'Altered gene expression in cell signalling pathways of midbrain dopamine neurons from addiction and relapse vulnerable animals', Drug and Alcohol Review: Abstracts of the Australasian Professional Society on Alcohol and other Drugs Conference 2012, Melbourne, Vic (2012) [E3]
Co-authors Jamie Flynn, Christopher Dayas
2012 Dayas CV, Quinn RK, Goldie BJ, Brown AM, Levi EM, Smith DW, Cairns MJ, 'Association of miRNAs with addiction-relevant synaptic plasticity genes', Abstract Book. Biological Psychiatry Australia Scientific Meeting, Parkville, Vic (2012) [E3]
Co-authors Christopher Dayas, Murray Cairns
2011 Thomas J, Smith DW, Garg ML, 'Dietary supplementation with resveratrol normalizes histone deacetylase (HDAC4) in the hippocampus of streptozotocin-induced diabetic mice', Australasian Medical Journal, Queenstown, NZ (2011) [E3]
Co-authors Manohar Garg
2011 Barreto RDA, Walker FR, Dunkley PR, Day TA, Smith DW, 'Alteration of neurotrophic factor pathway gene expression in the rat infralimbic medial prefrontal cortex by subchronic restraint stress is reversed by fluoxetine', Posters. Australian Neuroscience Society 31st Annual Meeting, Auckland, New Zealand (2011) [E3]
Co-authors Rohan Walker, Peter Dunkley, Trevor Day
2010 Thomas J, Smith DW, Garg ML, 'Dietary supplementation with resveratrol reduces erythrocyte arachidonic and docosahexaenoic acids levels in diabetic mice', Proceedings of the Nutrition Society of Australia, Perth, WA (2010) [E3]
Co-authors Manohar Garg
2007 McInerny SC, Brown AL, Smith DW, 'Brain region-specific decrease in mitochondrial D-loop in aged rats (Poster)', 7th IBRO 2007 World Congress of Neuroscience Program, Melbourne (2007) [E3]
2001 Smith DW, De-Gregorio L, Friedmann T, 'Modulator genes in Lesch Nyhan disease: Microarray studies.', AMERICAN JOURNAL OF HUMAN GENETICS (2001)
1995 Day TA, Smith DW, Buller KM, 'Regulation of neurosecretory cell activity by A1 noradrenergic neurons', 1st Joint World Congress of Neurohypophysis and Vasopressin, Nasu Japan (1995)
Citations Web of Science - 5
1995 Day TA, Smith DW, Buller KM, 'Activation of corticotrophin releasing factor cells by ventrolateral medulla catecholamine neurons', Journal of UOEH (1995)
Show 12 more conferences
Edit

Grants and Funding

Summary

Number of grants 21
Total funding $5,866,640

Click on a grant title below to expand the full details for that specific grant.


20221 grants / $144,000

Understanding how cholesterol dysregulation in the aging brain causes Alzheimer's Disease$144,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Associate Professor Doug Smith, Mr Ethan Cresswell
Scheme Research Grant
Role Lead
Funding Start 2022
Funding Finish 2024
GNo G2200946
Type Of Funding C3300 – Aust Philanthropy
Category 3300
UON Y

20182 grants / $907,715

Cognitive inflexibility and the development of pathological habits in brain diseases$897,715

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Chris Dayas, Professor Bernard Balleine, Dr Laura Corbit, Associate Professor Doug Smith, Professor Murray Cairns, Dr Billy Chieng, Professor Paul Kenny
Scheme Project Grant
Role Investigator
Funding Start 2018
Funding Finish 2020
GNo G1700396
Type Of Funding C1100 - Aust Competitive - NHMRC
Category 1100
UON Y

Investigation of Age-Related Neuro-Inflammatory and Neuro-Vascular Changes in the Central Nervous System$10,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Mr Mitchell Cummins, Associate Professor Doug Smith
Scheme Greaves Family Postgraduate Top Up Scholarship in Medical Research
Role Lead
Funding Start 2018
Funding Finish 2018
GNo G1900117
Type Of Funding C3300 – Aust Philanthropy
Category 3300
UON Y

20171 grants / $25,000

Cholesterol metabolism in the ageing brain – implications for dementia$25,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Associate Professor Doug Smith
Scheme Project Grant
Role Lead
Funding Start 2017
Funding Finish 2017
GNo G1700349
Type Of Funding C3300 – Aust Philanthropy
Category 3300
UON Y

20152 grants / $45,000

Maintaining our cognitive abilities as we grow old: preventing the effects of ageing on the brain$25,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Associate Professor Doug Smith, Professor Rohan Walker
Scheme Project Grant
Role Lead
Funding Start 2015
Funding Finish 2015
GNo G1500078
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

Dizzy and Deaf - restoring signals from the inner ear$20,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Associate Professor Rebecca Lim, Professor Alan Brichta, Conjoint Professor Robert Callister, Associate Professor Doug Smith
Scheme Project Grant
Role Investigator
Funding Start 2015
Funding Finish 2015
GNo G1501395
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

20131 grants / $35,000

Leica TP 1020 Automatic Tissue Processor for histology applications$35,000

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Pradeep Tanwar, Professor Eileen McLaughlin, Professor Xu Dong Zhang, Conjoint Professor Robert Callister, Associate Professor Phillip Dickson, Professor Hubert Hondermarck, Doctor Jean-Marie Sontag, Professor Dirk Van Helden, Associate Professor Doug Smith, Associate Professor Phil Jobling, Associate Professor Estelle Sontag, Associate Professor Paul Tooney, Associate Professor Susan Hua, Doctor Janet Bristow, Professor Jay Horvat, Prof LIZ Milward, Professor Adam McCluskey, Professor Brett Nixon, Associate Professor Rebecca Lim, Professor Alan Brichta
Scheme Equipment Grant
Role Investigator
Funding Start 2013
Funding Finish 2013
GNo G1201185
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

20122 grants / $313,375

The effects of ageing on the peripheral vestibular system. Can ageing-related functional decline be reduced or prevented?$298,375

Funding body: The Garnett Passe and Rodney Williams Memorial Foundation

Funding body The Garnett Passe and Rodney Williams Memorial Foundation
Project Team Associate Professor Doug Smith
Scheme Project Grant
Role Lead
Funding Start 2012
Funding Finish 2014
GNo G1100935
Type Of Funding C3200 – Aust Not-for Profit
Category 3200
UON Y

2011 Emerging Research Leaders Program$15,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Associate Professor Doug Smith
Scheme Emerging Research Leaders Program
Role Lead
Funding Start 2012
Funding Finish 2012
GNo G1200307
Type Of Funding Internal
Category INTE
UON Y

20111 grants / $25,000

Brain Mechanisms Conferring Psychostimulant Addiction$25,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Chris Dayas, Emeritus Professor Peter Dunkley, Associate Professor Doug Smith
Scheme Near Miss Grant
Role Investigator
Funding Start 2011
Funding Finish 2011
GNo G1001052
Type Of Funding Internal
Category INTE
UON Y

20104 grants / $649,000

Laser microdissection microscopy system for cell and development biology$350,000

Funding body: ARC (Australian Research Council)

Funding body ARC (Australian Research Council)
Project Team Professor Eileen McLaughlin, Conjoint Professor Keith Jones, Distinguished Emeritus Professor John Aitken, Professor Brett Nixon, Doctor Shaun Roman, Professor Alan Brichta, Doctor Rick Thorne, Associate Professor Doug Smith, Aprof DAVID McCurdy, Emeritus Professor Ray Rose, Professor Christopher Grof, Emeritus Professor Leonie Ashman, Professor Gordon Burns, Professor Brett Graham, Associate Professor Paul Tooney, Laureate Professor Roger Smith, Professor Paul Foster, Professor Trevor Day, Conjoint Professor Robert Callister
Scheme Linkage Infrastructure Equipment & Facilities (LIEF)
Role Investigator
Funding Start 2010
Funding Finish 2010
GNo G0190369
Type Of Funding Scheme excluded from IGS
Category EXCL
UON Y

Laser microdissection microscopy system for cell and development biology$215,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Eileen McLaughlin, Conjoint Professor Keith Jones, Distinguished Emeritus Professor John Aitken, Professor Brett Nixon, Doctor Shaun Roman, Professor Alan Brichta, Doctor Rick Thorne, Associate Professor Doug Smith, Aprof DAVID McCurdy, Emeritus Professor Ray Rose, Professor Christopher Grof, Emeritus Professor Leonie Ashman, Professor Gordon Burns, Professor Brett Graham, Associate Professor Paul Tooney, Laureate Professor Roger Smith, Professor Paul Foster, Professor Trevor Day, Conjoint Professor Robert Callister
Scheme Equipment Grant
Role Investigator
Funding Start 2010
Funding Finish 2010
GNo G1000874
Type Of Funding Internal
Category INTE
UON Y

Laser microdissection microscopy system for cell and development biology (HMRI contribution towards 2010 ARC LIEF grant)$50,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Professor Eileen McLaughlin, Conjoint Professor Keith Jones, Distinguished Emeritus Professor John Aitken, Professor Brett Nixon, Doctor Shaun Roman, Professor Alan Brichta, Doctor Rick Thorne, Associate Professor Doug Smith, Aprof DAVID McCurdy, Emeritus Professor Ray Rose, Professor Christopher Grof, Emeritus Professor Leonie Ashman, Professor Gordon Burns, Professor Brett Graham, Associate Professor Paul Tooney, Laureate Professor Roger Smith, Professor Paul Foster, Professor Trevor Day, Conjoint Professor Robert Callister
Scheme Equipment Grant
Role Investigator
Funding Start 2010
Funding Finish 2010
GNo G1000144
Type Of Funding Other Public Sector - State
Category 2OPS
UON Y

ABI 7500 Real Time PCR System $34,000

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Doctor Rick Thorne, Associate Professor Nikki Verrills, Professor Murray Cairns, Associate Professor Paul Tooney, Associate Professor Doug Smith, Professor Gordon Burns, Emeritus Professor Leonie Ashman, Conjoint Professor Keith Jones, Doctor Charles De Bock, Professor Chris Dayas, Professor Brett Graham, Doctor Martin Horan, Associate Professor Rebecca Lim, Doctor Severine Roselli Dayas, Doctor Larisa Bobrovskaya, Associate Professor Kathryn Skelding, Professor Rohan Walker, Doctor Jude Weidenhofer, Professor Philip Bolton, Professor Alan Brichta, Conjoint Professor Robert Callister, Professor Trevor Day, Associate Professor Phillip Dickson, Prof MANOHAR Garg, Associate Professor Phil Jobling, Professor Derek Laver, Associate Professor Eugene Nalivaiko, Emeritus Professor John Rostas
Scheme Equipment Grant
Role Investigator
Funding Start 2010
Funding Finish 2010
GNo G1000055
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

20081 grants / $538,500

Dopamine mechanisms conferring resilience to depression: A new antidepressant target$538,500

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Trevor Day, Emeritus Professor Peter Dunkley, Professor David Pow, Associate Professor Doug Smith
Scheme Project Grant
Role Investigator
Funding Start 2008
Funding Finish 2010
GNo G0187604
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

20072 grants / $40,000

Vulnerability to depression: the role of dopamine pathways$20,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Trevor Day, Emeritus Professor Peter Dunkley, Associate Professor Doug Smith, Professor David Pow
Scheme Near Miss Grant
Role Investigator
Funding Start 2007
Funding Finish 2007
GNo G0187196
Type Of Funding Internal
Category INTE
UON Y

Characterisation of the brain mechanisms linking vulnerability to stress and vulnerability to drug addiction$20,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Professor Trevor Day, Professor Chris Dayas, Associate Professor Doug Smith
Scheme Project Grant
Role Investigator
Funding Start 2007
Funding Finish 2007
GNo G0187255
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

20042 grants / $13,679

Characterisation of age-related gene expression changes in midbrain dopamine neurons$12,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Associate Professor Doug Smith
Scheme New Staff Grant
Role Lead
Funding Start 2004
Funding Finish 2004
GNo G0184998
Type Of Funding Internal
Category INTE
UON Y

Society for Neuroscience Annual Meeting, 23-27 October 2004$1,679

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Associate Professor Doug Smith
Scheme Travel Grant
Role Lead
Funding Start 2004
Funding Finish 2004
GNo G0184814
Type Of Funding Internal
Category INTE
UON Y

20031 grants / $2,489,371

Genetic aberrations in HPRT deficiency$2,489,371

Funding body: National Institute of Neurological Disorders (NIH)

Funding body National Institute of Neurological Disorders (NIH)
Project Team

Theodore Friedmann

Scheme Project
Role Investigator
Funding Start 2003
Funding Finish 2007
GNo
Type Of Funding External
Category EXTE
UON N

20011 grants / $641,000

Array screening for Lesch-Nyhan disese$641,000

Funding body: NICH (NIH)

Funding body NICH (NIH)
Project Team

Theodore Friedmann

Scheme R21
Role Investigator
Funding Start 2001
Funding Finish 2003
GNo
Type Of Funding External
Category EXTE
UON N
Edit

Research Supervision

Number of supervisions

Completed12
Current3

Current Supervision

Commenced Level of Study Research Title Program Supervisor Type
2023 PhD Understanding How Aging Impacts The Proteome To Make The Brain Susceptible To Developing Alzheimer’s Disease. PhD (Anatomy), College of Health, Medicine and Wellbeing, The University of Newcastle Principal Supervisor
2021 PhD Understanding the Early Stages of Alzheimer’s Disease PhD (Anatomy), College of Health, Medicine and Wellbeing, The University of Newcastle Principal Supervisor
2018 PhD Effect of Ageing on Central Nervous System Cholesterol Homeostasis PhD (Anatomy), College of Health, Medicine and Wellbeing, The University of Newcastle Principal Supervisor

Past Supervision

Year Level of Study Research Title Program Supervisor Type
2023 PhD Classical Approaches versus Modern Molecular Techniques to Dissect Neuronal Heterogeneity in the Dorsal Horn: Opposite Ends of the Same Spectrum? PhD (Human Physiology), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
2022 PhD Investigating the Processes of Age-Related Inflammation in the Central Nervous System PhD (Anatomy), College of Health, Medicine and Wellbeing, The University of Newcastle Principal Supervisor
2020 PhD Model Perturbations of Glial Synaptomodulatory and Immune Functions PhD (Anatomy), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
2019 PhD Ageing of the Inner Ear Vestibular Organs PhD (Anatomy), College of Health, Medicine and Wellbeing, The University of Newcastle Principal Supervisor
2018 PhD The Role of Mitochondrial DNA in the Post-Injury Inflammatory Response Following Major Trauma PhD (Medicine), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
2016 PhD Ageing of the Somatic Motor Nervous System: A Nuclear and Mitochondrial Genome Perspective PhD (Medical Biochemistry), College of Health, Medicine and Wellbeing, The University of Newcastle Principal Supervisor
2015 Masters Nucleotide Excision Repair of UVA-Induced DNA Damage: Regulation in Sunlight-Induced Melanoma M Philosophy (Medical Genetic), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
2014 PhD The Role of Cocaine- and Amphetamine-Regulated Transcript (CART) and Orexin in Drug-Seeking and Addiction-Related Behaviours PhD (Anatomy), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
2013 PhD Effects of Anti-Inflammatory Bioactives on Diabetes-Induced Changes in Cognition-Related Gene Expression in the Hippocampus PhD (Medical Biochemistry), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
2012 PhD Molecular Correlates of Dopamine Signalling in Addiction Vulnerability PhD (Anatomy), College of Health, Medicine and Wellbeing, The University of Newcastle Principal Supervisor
2012 PhD Dopaminergic Pathway Imbalance in the Neurobiology of Depression PhD (Anatomy), College of Health, Medicine and Wellbeing, The University of Newcastle Principal Supervisor
2006 Honours Role of mitochondrial D-loop in aging brain Medical Science, University of Newcastle Principal Supervisor
Edit

Associate Professor Doug Smith

Position

Associate Professor
School of Biomedical Sciences and Pharmacy
College of Health, Medicine and Wellbeing

Focus area

Anatomy

Contact Details

Email douglas.smith@newcastle.edu.au
Phone 0468473659
Mobile 0468473659
Fax N/A

Office

Room MS511
Building Medical Sciences
Location Callaghan
University Drive
Callaghan, NSW 2308
Australia
Edit